一项评估 CC-92480 联合 Carfilzomib 和地塞米松 (480Kd) 对比 Carfilzomib 和地塞米松 (Kd) 在复发或难治性多发性骨髓瘤参与者中的研究 (SUCCESSOR-2)
在复发或难治性多发性骨髓瘤 (RRMM) 参与者中比较 CC-92480 (BMS-986348)、卡非佐米和地塞米松 (480Kd) 与卡非佐米和地塞米松 (Kd) 的第 3 期、两阶段、随机、多中心、开放标签研究)
The purpose of the study is to compare Mezigdomide (CC-92480/BMS-986348) with carfilzomib and dexamethasone (MeziKD) against carfilzomib and dexamethasone (Kd) in the treatment of RRMM: SUCCESSOR-2.
研究概览
研究类型
注册 (实际的)
阶段
- 第三阶段
联系人和位置
学习地点
-
-
-
Taiyuan、中国、030032
- Local Institution - 0059
-
-
Beijing Municipality
-
Beijing、Beijing Municipality、中国、100020
- Local Institution - 0061
-
Beijing、Beijing Municipality、中国、100043
- Local Institution - 0057
-
Beijing、Beijing Municipality、中国、100730
- Local Institution - 0056
-
-
Fujian
-
Fuzhou、Fujian、中国、350000
- Local Institution - 0123
-
-
Guangdong
-
Guangzhou、Guangdong、中国、510000
- Local Institution - 0138
-
-
Henan
-
Zhengzhou、Henan、中国、450008
- Local Institution - 0051
-
-
Hubei
-
Wuhan、Hubei、中国、430002
- Local Institution - 0066
-
Wuhan、Hubei、中国、430030
- Local Institution - 0054
-
-
Hunan
-
Changsha、Hunan、中国、410013
- Local Institution - 0071
-
Changsha、Hunan、中国、410013
- Local Institution - 0103
-
-
Jiangsu
-
Nanjing、Jiangsu、中国、210009
- Local Institution - 0180
-
Nantong、Jiangsu、中国、226001
- Local Institution - 0111
-
Suzhou、Jiangsu、中国、215006
- Local Institution - 0104
-
Wuxi、Jiangsu、中国、214023
- Local Institution - 0069
-
-
Jiangxi
-
Nanchang、Jiangxi、中国、330006
- Local Institution - 0095
-
-
Jilin
-
Changchun、Jilin、中国、130021
- Local Institution - 0052
-
-
Liaoning
-
Shenyang、Liaoning、中国、110001
- Local Institution - 0096
-
Shenyang、Liaoning、中国、110004
- Local Institution - 0176
-
-
Shaanxi
-
Xi'an、Shaanxi、中国、710126
- Local Institution - 0060
-
-
Shandong
-
Jinan、Shandong、中国、250012
- Local Institution - 0072
-
-
Shanghai Municipality
-
Shanghai、Shanghai Municipality、中国、200025
- Local Institution - 0118
-
Shanghai、Shanghai Municipality、中国、200080
- Local Institution - 0317
-
-
Tianjin Municipality
-
Tianjin、Tianjin Municipality、中国、300060
- Local Institution - 0091
-
-
Yunnan
-
Kunming、Yunnan、中国、650101
- Local Institution - 0058
-
-
Zhejiang
-
Hangzhou、Zhejiang、中国、310003
- Local Institution - 0050
-
Wenzhou、Zhejiang、中国、32500
- Local Institution - 0115
-
-
-
-
-
Vejle、丹麦、7100
- Local Institution - 0125
-
-
Central Jutland
-
Aarhus、Central Jutland、丹麦、8200
- Local Institution - 0032
-
-
Region Sjælland
-
Roskilde、Region Sjælland、丹麦、4000
- Local Institution - 0065
-
-
Region Syddanmark
-
Odense、Region Syddanmark、丹麦、5000
- Local Institution - 0129
-
-
-
-
-
Jerusalem、以色列、9112001
- Local Institution - 0277
-
-
Central District
-
Holon、Central District、以色列、5810001
- Local Institution - 0264
-
Tsrifin、Central District、以色列、70300
- Local Institution - 0267
-
-
-
-
-
Plovdiv、保加利亚、4002
- Local Institution - 0305
-
Sofia、保加利亚、1407
- Local Institution - 0309
-
Sofia、保加利亚、1431
- Local Institution - 0304
-
-
-
-
Nova Scotia
-
Halifax、Nova Scotia、加拿大、B3H 2Y9
- Local Institution - 0183
-
-
Ontario
-
London、Ontario、加拿大、N6A 5W9
- Local Institution - 0275
-
Toronto、Ontario、加拿大、M5G 2M9
- Local Institution - 0184
-
-
-
-
-
Budapest、匈牙利、1088
- Local Institution - 0042
-
Budapest、匈牙利、1097
- Local Institution - 0019
-
-
Baranya
-
Pécs、Baranya、匈牙利、7624
- Local Institution - 0036
-
-
Hajdú-Bihar
-
Debrecen、Hajdú-Bihar、匈牙利、4032
- Local Institution - 0043
-
-
Szabolcs-Szatmár-Bereg
-
Nyíregyháza、Szabolcs-Szatmár-Bereg、匈牙利、4400
- Local Institution - 0094
-
-
-
-
-
Chandigarh、印度、160012
- Local Institution - 0230
-
-
Haryana
-
Gurgaon、Haryana、印度、122001
- Local Institution - 0167
-
-
Karnataka
-
Bengaluru、Karnataka、印度、560027
- Local Institution - 0161
-
-
Maharashtra
-
Mumbai、Maharashtra、印度、400012
- Local Institution - 0168
-
Thane、Maharashtra、印度、400602
- Local Institution - 0171
-
-
National Capital Territory of Delhi
-
New Delhi、National Capital Territory of Delhi、印度、110085
- Local Institution - 0170
-
-
Punjab
-
Mohali、Punjab、印度、160055
- Local Institution - 0261
-
-
Tamil Nadu
-
Chennai、Tamil Nadu、印度、600036
- Local Institution - 0174
-
-
Telangana
-
Hyderabad、Telangana、印度、500033
- Local Institution - 0165
-
Hyderabad、Telangana、印度、500068
- Local Institution - 0310
-
Hyderabad、Telangana、印度、500084
- Local Institution - 0164
-
-
-
-
-
Kaohsiung City、台湾、82445
- Local Institution - 0012
-
Taichung、台湾、407
- Local Institution - 0001
-
Tainan、台湾、704
- Local Institution - 0002
-
Taipei、台湾、11217
- Local Institution - 0162
-
-
Chiayi
-
Chiayi City、Chiayi、台湾、613
- Local Institution - 0274
-
-
Kaohsiung
-
Kaohsiung Niao Sung Dist、Kaohsiung、台湾、83301
- Local Institution - 0177
-
-
-
-
-
Cali、哥伦比亚、760035
- Local Institution - 0155
-
-
Antioquia
-
Medellín、Antioquia、哥伦比亚、05034
- Local Institution - 0153
-
-
Cesar Department
-
Valledupar、Cesar Department、哥伦比亚、200001
- Local Institution - 0156
-
-
Cundinamarca
-
Bogota、Cundinamarca、哥伦比亚、111151
- Local Institution - 0154
-
-
Santander Department
-
Piedecuesta、Santander Department、哥伦比亚、681017
- Local Institution - 0324
-
-
-
-
-
Linz、奥地利、4020
- Local Institution - 0020
-
Vienna、奥地利、1090
- Local Institution - 0017
-
-
State of Vienna
-
Vienna、State of Vienna、奥地利、1060
- Local Institution - 0266
-
-
-
-
-
Rio de Janeiro、巴西、20775-001
- Local Institution - 0075
-
São Paulo、巴西、04537-080
- Local Institution - 0073
-
-
Estado de Bahia
-
Salvador、Estado de Bahia、巴西、41253-190
- Local Institution - 0121
-
-
Rio Grande do Sul
-
Porto Alegre、Rio Grande do Sul、巴西、90470-340
- Local Institution - 0076
-
-
São Paulo
-
São Paulo、São Paulo、巴西、01509-010
- Local Institution - 0085
-
-
-
-
Achaḯa
-
Pátrai、Achaḯa、希腊、26504
- Local Institution - 0136
-
-
Attikí
-
Athens、Attikí、希腊、11528
- Local Institution - 0135
-
-
Thessaloníki
-
Thessaloniki、Thessaloníki、希腊、570 10
- Local Institution - 0134
-
-
-
-
-
Berlin、德国、12203
- Local Institution - 0007
-
Cologne、德国、50937
- Local Institution - 0102
-
Dresden、德国、01307
- Local Institution - 0329
-
Düsseldorf、德国、40479
- Local Institution - 0334
-
Heidelberg、德国、D-69120
- Local Institution - 0015
-
Leipzig、德国、04103
- Local Institution - 0030
-
Nuremberg、德国、90419
- Local Institution - 0133
-
Würzburg、德国、97080
- Local Institution - 0014
-
-
Baden-Wurttemberg
-
Ulm、Baden-Wurttemberg、德国、89081
- Local Institution - 0124
-
-
Bavaria
-
Munich、Bavaria、德国、81241
- Local Institution - 0330
-
-
Lower Saxony
-
Hanover、Lower Saxony、德国、30161
- Local Institution - 0333
-
-
North Rhine-Westphalia
-
Dortmund、North Rhine-Westphalia、德国、44263
- Local Institution - 0335
-
-
Schleswig-Holstein
-
Kiel、Schleswig-Holstein、德国、24105
- Local Institution - 0029
-
-
Thuringia
-
Jena、Thuringia、德国、07747
- Local Institution - 0331
-
-
-
-
-
Bologna、意大利、40138
- Local Institution - 0189
-
Catanzaro、意大利、88100
- Local Institution - 0148
-
Lecce、意大利、73100
- Local Institution - 0147
-
Pisa、意大利、56100
- Local Institution - 0144
-
Udine、意大利、33100
- Local Institution - 0146
-
-
Emilia-Romagna
-
Meldola、Emilia-Romagna、意大利、47014
- Local Institution - 0145
-
-
Lombardy
-
Milan、Lombardy、意大利、20122
- Local Institution - 0143
-
-
Milano
-
Rozzano、Milano、意大利、20089
- Local Institution - 0142
-
-
-
-
-
Oslo、挪威、0450
- Local Institution - 0081
-
-
Hordaland
-
Bergen、Hordaland、挪威、5021
- Local Institution - 0049
-
-
Rogaland
-
Stavanger、Rogaland、挪威、4021
- Local Institution - 0112
-
-
-
-
Central Singapore
-
Singapore、Central Singapore、新加坡、119074
- Local Institution - 0158
-
Singapore、Central Singapore、新加坡、169608
- Local Institution - 0159
-
-
-
-
-
Chiba、日本、260-8677
- Local Institution - 0215
-
Fukuoka、日本、810-8563
- Local Institution - 0226
-
Fukuoka、日本、815-8555
- Local Institution - 0235
-
Kumamoto、日本、860-8556
- Local Institution - 0220
-
Kyoto、日本、602-8566
- Local Institution - 0216
-
Nagasaki、日本、852-8104
- Local Institution - 0213
-
Okayama、日本、701-1192
- Local Institution - 0212
-
Osaka、日本、545-8586
- Local Institution - 0301
-
Tokyo、日本、105-8461
- Local Institution - 0241
-
Tokyo、日本、150-8935
- Local Institution - 0218
-
-
Aichi-ken
-
Nagoya、Aichi-ken、日本、467-8602
- Local Institution - 0269
-
-
Chiba
-
Kashiwa、Chiba、日本、277-8577
- Local Institution - 0214
-
-
Fukuoka
-
Kitakyushu-shi、Fukuoka、日本、806-8501
- Local Institution - 0210
-
-
Hokkaido
-
Sapporo、Hokkaido、日本、003-0804
- Local Institution - 0211
-
-
Ibaraki
-
Higashiibaraki、Ibaraki、日本、3113117
- Local Institution - 0217
-
-
Ishikawa-ken
-
Kanazawa、Ishikawa-ken、日本、920-8641
- Local Institution - 0300
-
-
Iwate
-
Shiwa-gun Yahaba-cho、Iwate、日本、028-3695
- Local Institution - 0209
-
-
Kanagawa
-
Kamakura、Kanagawa、日本、247-8533
- Local Institution - 0234
-
-
Saitama
-
Koshigaya、Saitama、日本、343-0845
- Local Institution - 0225
-
-
Tokyo
-
Koto-ku、Tokyo、日本、135-8550
- Local Institution - 0219
-
tabashi City、Tokyo、日本、173-8610
- Local Institution - 0236
-
-
Yamanashi
-
Chūō、Yamanashi、日本、409-3898
- Local Institution - 0303
-
-
-
-
-
San Juan、波多黎各、00909
- Local Institution - 0316
-
-
-
-
New South Wales
-
Camperdown、New South Wales、澳大利亚、2050
- Local Institution - 0077
-
Gosford、New South Wales、澳大利亚、2250
- Local Institution - 0160
-
Port Macquarie、New South Wales、澳大利亚、2444
- Local Institution - 0263
-
St Leonards、New South Wales、澳大利亚、2065
- Local Institution - 0078
-
Sydney、New South Wales、澳大利亚、2010
- Local Institution - 0026
-
-
South Australia
-
Adelaide、South Australia、澳大利亚、5000
- Local Institution - 0024
-
-
Victoria
-
Bendigo、Victoria、澳大利亚、3550
- Local Institution - 0131
-
East Melbourne、Victoria、澳大利亚、3002
- Local Institution - 0224
-
Heidelberg、Victoria、澳大利亚、3084
- Local Institution - 0127
-
Melbourne、Victoria、澳大利亚、3065
- Local Institution - 0025
-
-
-
-
-
Brasov、罗马尼亚、500052
- Local Institution - 0284
-
Bucharest、罗马尼亚、022328
- Local Institution - 0302
-
Bucharest、罗马尼亚、030171
- Local Institution - 0287
-
Sibiu、罗马尼亚、557260
- Local Institution - 0306
-
-
Bucharest
-
Bucharest、Bucharest、罗马尼亚、022328
- Local Institution - 0282
-
-
-
-
Alabama
-
Mobile、Alabama、美国、36604
- Local Institution - 0046
-
-
California
-
Cerritos、California、美国、90703
- Local Institution - 0005
-
Irvine、California、美国、92618
- Local Institution - 0190
-
Los Angeles、California、美国、90017
- Local Institution - 0187
-
Santa Rosa、California、美国、95403
- Local Institution - 0344
-
Stockton、California、美国、95204
- Local Institution - 0339
-
-
Florida
-
Fort Myers、Florida、美国、33901
- Local Institution - 0341
-
St. Petersburg、Florida、美国、33705
- Local Institution - 0342
-
West Palm Beach、Florida、美国、33401
- Local Institution - 0340
-
-
Georgia
-
Atlanta、Georgia、美国、30303
- Local Institution - 0348
-
Atlanta、Georgia、美国、30322
- Local Institution - 0291
-
-
Idaho
-
Boise、Idaho、美国、83706
- Saint Alphonsus Regional Medical Center
-
-
Maryland
-
Annapolis、Maryland、美国、21401
- Local Institution - 0289
-
-
Massachusetts
-
Boston、Massachusetts、美国、02215
- Local Institution - 0204
-
-
Minnesota
-
Minneapolis、Minnesota、美国、55404
- Local Institution - 0346
-
-
New Jersey
-
Little Silver、New Jersey、美国、07739
- Local Institution - 0222
-
-
New York
-
The Bronx、New York、美国、10467
- Local Institution - 0199
-
-
Ohio
-
Cleveland、Ohio、美国、44106
- Local Institution - 0322
-
Columbus、Ohio、美国、43214
- Local Institution - 0172
-
-
Rhode Island
-
Providence、Rhode Island、美国、02903
- Local Institution - 0321
-
-
South Carolina
-
Greer、South Carolina、美国、29650
- Local Institution - 0338
-
-
Tennessee
-
Chattanooga、Tennessee、美国、37404
- Local Institution - 0349
-
Nashville、Tennessee、美国、37203
- Local Institution - 0323
-
-
Texas
-
Fort Worth、Texas、美国、76104
- Local Institution - 0337
-
Houston、Texas、美国、77025
- Local Institution - 0328
-
Houston、Texas、美国、77030
- Local Institution - 0044
-
Temple、Texas、美国、76508
- Local Institution - 0195
-
-
Virginia
-
Norfolk、Virginia、美国、23502
- Local Institution - 0345
-
Roanoke、Virginia、美国、24014
- Local Institution - 0343
-
-
Washington
-
Tacoma、Washington、美国、98405
- Local Institution - 0006
-
Vancouver、Washington、美国、98684
- Local Institution - 0347
-
-
West Virginia
-
Morgantown、West Virginia、美国、26506
- Local Institution - 0243
-
-
Wisconsin
-
Marshfield、Wisconsin、美国、54449
- Local Institution - 0336
-
-
-
-
-
Birmingham、英国、B9 5SS
- Local Institution - 0273
-
Leeds、英国、LS9 7TF
- Local Institution - 0080
-
Taunton、英国、TA1 5DA
- Local Institution - 0040
-
-
Devon
-
Plymouth、Devon、英国、Pl6 8DH
- Local Institution - 0139
-
-
England
-
Cringleford、England、英国、NR4 7UY
- Local Institution - 0067
-
-
Glasgow City
-
Glasgow、Glasgow City、英国、G12 0YN
- Local Institution - 0196
-
-
-
-
-
Enschede、荷兰、7512 KZ
- Local Institution - 0194
-
-
North Brabant
-
Breda、North Brabant、荷兰、4818 CK
- Local Institution - 0113
-
-
-
-
-
Granada、西班牙、18012
- Local Institution - 0107
-
Madrid、西班牙、28015
- Local Institution - 0047
-
Málaga、西班牙、29010
- Local Institution - 0105
-
-
Barcelona [Barcelona]
-
Badalona、Barcelona [Barcelona]、西班牙、08916
- Local Institution - 0126
-
Barcelona、Barcelona [Barcelona]、西班牙、08035
- Local Institution - 0092
-
L'Hospitalet Del Llobregat、Barcelona [Barcelona]、西班牙、08908
- Local Institution - 0038
-
-
Madrid, Comunidad de
-
Madrid、Madrid, Comunidad de、西班牙、28009
- Local Institution - 0200
-
Majadahonda、Madrid, Comunidad de、西班牙、28222
- Local Institution - 0108
-
-
Santa Cruz De Tenerife
-
San Cristóbal de La Laguna、Santa Cruz De Tenerife、西班牙、38320
- Local Institution - 0201
-
-
Valenciana, Comunitat
-
Valencia、Valenciana, Comunitat、西班牙、46010
- Local Institution - 0037
-
-
-
-
-
Buenos Aires、阿根廷、1431
- Local Institution - 0150
-
Córdoba、阿根廷、5000
- Local Institution - 0151
-
-
Buenos Aires
-
Ciudad Autónoma de Buenos Aires、Buenos Aires、阿根廷、C1426ANZ
- Local Institution - 0008
-
-
Buenos Aires F.D.
-
ABB、Buenos Aires F.D.、阿根廷、C1199ABB
- Local Institution - 0079
-
-
Santa Fe Province
-
Rosario、Santa Fe Province、阿根廷、2000
- Local Institution - 0182
-
-
Tucumán Province
-
San Miguel de Tucumán、Tucumán Province、阿根廷、4000
- Local Institution - 0319
-
-
-
-
Seoul-teukbyeolsi [Seoul]
-
Seoul、Seoul-teukbyeolsi [Seoul]、韩国、03080
- Local Institution - 0238
-
Seoul、Seoul-teukbyeolsi [Seoul]、韩国、06351
- Local Institution - 0239
-
Seoul、Seoul-teukbyeolsi [Seoul]、韩国、06591
- Local Institution - 0240
-
-
-
-
-
Hksar、香港
- Local Institution - 0178
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria
- Participant has documented diagnosis of multiple myeloma and measurable disease, defined as any of the following:.
i) Myeloma-protein (M-protein) ≥ 0.5 grams/deciliter (g/dL) by serum protein electrophoresis (sPEP), or.
ii) M-protein ≥ 200 milligrams (mg)/24-hour urine collection by urine protein electrophoresis (uPEP) or,.
iii) For participants without measurable disease in sPEP or uPEP: serum free light chain levels > 100 mg/liter (L) (10 mg/dL) involved light chain and an abnormal κ/λ free light chain ratio.
- Participant has received at least one prior line of anti-myeloma therapy. Note: One line can contain several phases (e.g., induction, [with or without] hematopoietic stem cell transplant, (with or without) consolidation, and/or [with or without] maintenance therapy).
- Participant must have received prior treatment with lenalidomide and at least 2 cycles of an anti-CD38 monoclonal antibody (mAb) (participants who were intolerant of an anti-CD38 mAb and received < 2 cycles are still eligible).
- Participant achieved minimal response or better to at least 1 prior anti-myeloma therapy.
- Participant must have documented disease progression during or after their last antimyeloma regimen.
Exclusion Criteria
- Participant who has had prior treatment with mezigdomide or carfilzomib.
- Participant has previously received allogeneic stem cell transplant at any time or received autologous stem cell transplant within 12 weeks of initiating study treatment.
- Other protocol-defined Inclusion/Exclusion criteria apply.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器:Kd(卡非佐米+地塞米松)
|
Specified dose on specified days
其他名称:
Specified dose on specified days
其他名称:
|
|
实验性的:MeziKd(美齐格多胺 + 卡非佐米 + 地塞米松)
|
Specified dose on specified days
其他名称:
Specified dose on specified days
其他名称:
Specified dose on specified days
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
无进展生存期 (PFS)
大体时间:最长约 5 年
|
最长约 5 年
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
无进展生存期 2 (PFS-2)
大体时间:最长约 5 年
|
最长约 5 年
|
|
|
总生存期(OS)
大体时间:最长约 5 年
|
最长约 5 年
|
|
|
响应时间 (TTR)
大体时间:最长约 5 年
|
最长约 5 年
|
|
|
反应持续时间 (DOR)
大体时间:最长约 5 年
|
最长约 5 年
|
|
|
进展时间 (TTP)
大体时间:最长约 5 年
|
最长约 5 年
|
|
|
下次治疗时间 (TTNT)
大体时间:最长约 5 年
|
最长约 5 年
|
|
|
微小残留病 (MRD) 阴性率
大体时间:最长约 5 年
|
最长约 5 年
|
|
|
发生不良事件 (AE) 的参与者人数
大体时间:最长约 5 年
|
最长约 5 年
|
|
|
总体反应 (OR)
大体时间:最长约 5 年
|
最长约 5 年
|
|
|
Recommended Mezigdomide Dose
大体时间:Up to 12 months
|
Stage 1 only |
Up to 12 months
|
|
Plasma concentrations of Mezigdomide in Combination with Carfilzomib and Dexamethasone
大体时间:Up to 176 days
|
Stage 1 only |
Up to 176 days
|
|
Rate Of Very Good Partial Response (VGPR) Or Better (VGPRR)
大体时间:Up to approximately 5 years
|
VGPRR will be calculated as the percentage of participants who achieve best response of VGPR or better according to the International Myeloma Working Group (IMWG) Uniform Response Criteria for Multiple Myeloma. |
Up to approximately 5 years
|
|
Complete Response (CR) Or Better (CRR)
大体时间:Up to approximately 5 years
|
CRR will be calculated as the percentage of participants who achieve best response of CR or better according to the IMWG Uniform Response Criteria for Multiple Myeloma. |
Up to approximately 5 years
|
|
Change From Baseline in the European Organization for Research and Treatment of Cancer - Quality of Life C30 Questionnaire (EORTC QLQ-C30)
大体时间:Up to approximately 5 years
|
The EORTC QLQ-C30 is the most commonly used quality of life instrument in oncology trials. The QLQ-C30 consists of 30 questions incorporated into 5 functional domains physical, role, cognitive, emotional, and social), 9 symptom/other scales (fatigue, pain, nausea and vomiting, dyspnea, insomnia, appetite loss, constipation, diarrhea, and financial difficulties), and a single global Quality of Life (QoL)/global health status score. Items in the functional and symptom scale use raw participant response of 1 to 4, where 1 = "not at all" and 4 = "very much." The 2 global items contain responses ranging from 1 "very poor" to 7 "excellent." The recall period is 1 week. All domain scores are transformed in a range from 0 to 100, where a higher functional score indicates more favorable outcomes and a higher score on the symptom domains indicates a less favorable participant outcome. Stage 2 only. |
Up to approximately 5 years
|
|
Change From Baseline in the European Quality of Life Multiple Myeloma Module (EORTC QLQ-MY20)
大体时间:Up to approximately 5 years
|
The EORTC QLQ-MY20 is a 20-item myeloma module intended for use among participants varying in disease stage and treatment modality. Participants rate symptoms or problems on a scale from 1 to 4 where 1 = "not at all" and 4 = "very much." Stage 2 only. |
Up to approximately 5 years
|
合作者和调查者
调查人员
- 研究主任:Bristol-Myers Squibb、Bristol-Myers Squibb
出版物和有用的链接
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- CA057-008
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
BMS will provide access to individual anonymized participant data upon request from qualified researchers, and subject to certain criteria. Additional information regarding Bristol Myer Squibb's data sharing policy and process can be found at https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html
IPD 共享时间框架
See Plan Description
IPD 共享访问标准
See Plan Description
IPD 共享支持信息类型
- 研究方案
- 树液
- 企业社会责任
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.